White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously

The Food and Drug Administration is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorised for emergency use in the US

Pfizer has shipped around 40 million doses to locations across the United States so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer's chief business officer

Pfizer Inc has withdrawn its application for emergency-use authorization of its COVID-19 vaccine in India that it had developed with Germany's BioNTech. The US company, which was the first drugmaker to apply for emergency use authorization of its coronavirus vaccine in India, had a meeting with the country's drugs regulator on Wednesday and the decision was made after that, the company said. India's Central Drugs Standard Control Organisation had declined to accept Pfizer's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians. Watch the video for more.Also Read: Pfizer withdraws emergency use application for COVID-19 vaccine in India

The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses

Vaccines are not yet approved for children, but testing already is underway for those as young as 12

The American biotech company said its two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower overall rates of infection

Public health officials are increasingly counting on single-dose options like the one being tested by J&J to simplify and boost inoculations given the complications and slower-than-hoped rollout of authorized vaccines from Pfizer and Moderna

Pai was named US FCC chairman in January 2017 by ex-president Donald Trump. He stepped down on Wednesday

The pre-prints or preliminary reports of research work related to Covaxin, which are yet to be peer-reviewed are already posted on pre-print servers like bioRxiv, medRxiv and Research Square

Pfizer is yet to submit additional data sought by India authorities regarding its COVID-19 vaccine for granting emergency use approval to it; the company has missed last three SEC meetings too

A major incident is defined as one in which there is a risk to life and welfare and is \"beyond the scope of business-as-usual operations. It allows coordination between different emergency agencies and will let London ask for help from other areas

Israel has begun to vaccinate its population at one of the quickest rates in the world, and it aims to reach all vulnerable citizens by late January

COVID-19 vaccine update: India has approved two coronavirus vaccines for emergency use - Bharat Biotech-ICMR's Covaxin and Covishield manufactured by Pune's Serum Institute

Pune-based SII is to submit an updated safety data of phase 2 and 3 clinical trials in India, immunogenicity data from the clinical trial in the UK and India, as well as the assessment results of the UK Medicines and Healthcare products Regulatory Agency

The Indian government is considering emergency use authorization for three vaccine candidates - one from AstraZeneca, another from Pfizer, and a separate one developed by the Indian firm Bharat Biotech

Post an expert meeting on Monday, the EMA declared their recommendation that the shot be licensed for use in people over the age of 16 years, barring some exceptions

More than Rs 7 lakh crore of investor wealth was eroded in a single session as Sensex fell 2,037 points to 44,923, its day's low and Nifty lost 628 points to the intraday low of 13,131

India Stock Market Highlights Today: Global equities were bearish today as coronavirus infections increased in parts of North Asia, such as Japan and South Korea, and weighed on investor sentiment. European countries have banned flights from the UK as the British government began emergency lockdown on Sunday, over fear of new virus strain.

Amid record coronavirus infections and deaths, Moderna has already moved vaccine supplies from its manufacturing plants to warehouses operated by distributor McKesson Corp